Cargando…
Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis
OBJECTIVE: The mechanism of Panax notoginseng in treating myocardial fibrosis (MF) was investigated using network pharmacology. METHODS: Effective ingredients and potential targets of Panax notoginseng were screened in relevant databases to construct a compound-target network. Targets of MF were the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975676/ https://www.ncbi.nlm.nih.gov/pubmed/35372585 http://dx.doi.org/10.1155/2022/8895950 |
_version_ | 1784680416290013184 |
---|---|
author | Han, Jingxue Hou, Jingyi Liu, Yu Liu, Peng Zhao, Tingting Wang, Xinwei |
author_facet | Han, Jingxue Hou, Jingyi Liu, Yu Liu, Peng Zhao, Tingting Wang, Xinwei |
author_sort | Han, Jingxue |
collection | PubMed |
description | OBJECTIVE: The mechanism of Panax notoginseng in treating myocardial fibrosis (MF) was investigated using network pharmacology. METHODS: Effective ingredients and potential targets of Panax notoginseng were screened in relevant databases to construct a compound-target network. Targets of MF were then screened to select common targets and construct a protein-protein interaction network. This was followed by Gene Ontology and pathway enrichment analyses. Molecular docking then verified the results of network analysis. RESULTS: A total of 14 effective ingredients and 119 potential targets for MF were predicted. Quercetin, beta-sitosterol, and gossypetin were speculated to be the main active ingredients. The mechanism of action may be related to AGE-RAGE, proteoglycans, and IL-17 signaling pathways. Five key targets (IL6, ALB, AKT1, TNF, and VEGFA) may be involved in the treatment of MF using Panax notoginseng. CONCLUSIONS: This study embodies the complex network relationship of multicomponents, multitargets, and multipathways of Panax notoginseng in treating MF and provides a novel method for further research on this herb's mechanism. |
format | Online Article Text |
id | pubmed-8975676 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-89756762022-04-02 Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis Han, Jingxue Hou, Jingyi Liu, Yu Liu, Peng Zhao, Tingting Wang, Xinwei J Diabetes Res Research Article OBJECTIVE: The mechanism of Panax notoginseng in treating myocardial fibrosis (MF) was investigated using network pharmacology. METHODS: Effective ingredients and potential targets of Panax notoginseng were screened in relevant databases to construct a compound-target network. Targets of MF were then screened to select common targets and construct a protein-protein interaction network. This was followed by Gene Ontology and pathway enrichment analyses. Molecular docking then verified the results of network analysis. RESULTS: A total of 14 effective ingredients and 119 potential targets for MF were predicted. Quercetin, beta-sitosterol, and gossypetin were speculated to be the main active ingredients. The mechanism of action may be related to AGE-RAGE, proteoglycans, and IL-17 signaling pathways. Five key targets (IL6, ALB, AKT1, TNF, and VEGFA) may be involved in the treatment of MF using Panax notoginseng. CONCLUSIONS: This study embodies the complex network relationship of multicomponents, multitargets, and multipathways of Panax notoginseng in treating MF and provides a novel method for further research on this herb's mechanism. Hindawi 2022-03-25 /pmc/articles/PMC8975676/ /pubmed/35372585 http://dx.doi.org/10.1155/2022/8895950 Text en Copyright © 2022 Jingxue Han et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Han, Jingxue Hou, Jingyi Liu, Yu Liu, Peng Zhao, Tingting Wang, Xinwei Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis |
title | Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis |
title_full | Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis |
title_fullStr | Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis |
title_full_unstemmed | Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis |
title_short | Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis |
title_sort | using network pharmacology to explore the mechanism of panax notoginseng in the treatment of myocardial fibrosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975676/ https://www.ncbi.nlm.nih.gov/pubmed/35372585 http://dx.doi.org/10.1155/2022/8895950 |
work_keys_str_mv | AT hanjingxue usingnetworkpharmacologytoexplorethemechanismofpanaxnotoginsenginthetreatmentofmyocardialfibrosis AT houjingyi usingnetworkpharmacologytoexplorethemechanismofpanaxnotoginsenginthetreatmentofmyocardialfibrosis AT liuyu usingnetworkpharmacologytoexplorethemechanismofpanaxnotoginsenginthetreatmentofmyocardialfibrosis AT liupeng usingnetworkpharmacologytoexplorethemechanismofpanaxnotoginsenginthetreatmentofmyocardialfibrosis AT zhaotingting usingnetworkpharmacologytoexplorethemechanismofpanaxnotoginsenginthetreatmentofmyocardialfibrosis AT wangxinwei usingnetworkpharmacologytoexplorethemechanismofpanaxnotoginsenginthetreatmentofmyocardialfibrosis |